Latigo Biotherapeutics, Inc. LTGO
Set alert
14.94 USD +1.43 +10.58%
As of Nov 3, 11:07 AM ET
13.53 Day range 15.10
13.26 52-week range 25.93
- YTD
- -18.14%
- 1 year
- -18.14%
- Open
- 13.53
- Prev close
- 13.51
- Mkt cap
- 990.51M
- Vol
- 75.83K
- Avg vol
- 337.48K
- EPS
- -2.52
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 13.53
- High
- 15.10
- Forward P/E
- -7.44
- Beta
- 0.00
- Short ratio
- 1.91
- Inst. own
- 80.73%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 19.18
- 200-d avg
- 19.18
- 1y target
- 52.25
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 52.25 +249.7% upside
Now 14.94
- Target (low)
- 36.00
- Target (mean)
- 52.25
- Target (high)
- 73.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy0
- Buy4
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.67 | -0.69 – -0.65 | 0.00 | 0.0% | 0 | 0.0% | 2 |
| Next quarter | -0.85 | -0.86 – -0.84 | 0.00 | 0.0% | 0 | 0.0% | 2 |
| Current year | -3.01 | -4.52 – -2.11 | -129.26 | +97.7% | 0 | 0.0% | 3 |
| Next year | -2.32 | -2.76 – -2.07 | -3.01 | +23.0% | 0 | 0.0% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 1, 2026 | Leerink Partners | Initiated | — | Outperform |
| Sep 1, 2026 | Jefferies | Initiated | — | Buy |
| Sep 1, 2026 | Guggenheim | Initiated | — | Buy |